Searchable abstracts of presentations at key conferences in endocrinology

ea0070ep507 | Thyroid | ECE2020

What is responsible for subacute thyroiditis? Virus or immune system: A case report

Geneș Dilek , Pekkolay Zafer , Güven Mehmet , Şimșek Mehmet , Saraçoğlu Hüsna , Kemal Tuzcu Alpaslan

Background: Subacute thyroiditis (SAT) is a transient thyrotoxic state characterized by suppressed TSH and low uptake of iodine 123 on thyroid scanning. SAT is a self limiting, possibly viral and inflammatory thyroid disorder that is usually associated with thyroid pain and systemic symptoms. Many factors can cause SAT. Infections are considered the most common cause. Vaccines can also lead to SAT.Case report: A 46-year-old male with a history of type 1 ...

ea0014p451 | (1) | ECE2007

Familial hypocalciuric hypercalcemia: mutation in the calcium sensing receptor gene

Paiva Sandra , Ribeiro Cristina , Barros Luisa , Gomes Leonor , Melo Miguel , Guimarães Joana , Venâncio Margarida , Saraiva Jorge , Carvalheiro Manuela

Familial hypocalciuria hypercalcemia (FHH) is an autossomal dominant condition caused by mutations in the calcium sensing receptor gene. It is characterized by moderate hypercalcemia, with normal or slightly elevated PTH levels and hypocalciuria secondary to the increased calcium reabsorption at the distal tubule level.We present a case report of a 16 year old patient, who was referred to our department at the age of 14 because of obesity (BMI: 36.9 K/m<...

ea0032p982 | Thyroid (non-cancer) | ECE2013

PRIMARA: a prospective descriptive observational study to review cinacalcet use in patients with primary hyperparathyroidism in clinical practice

Schwartz Peter , Body Jean-Jacques , Cap Jan , Hofbauer Lorenz , Farouk Mourad , Gessl Alois , Kuhn Marc , Marcocci Claudio , Mattin Caroline , Munoz Torres Manuel , Payer Juraj , van de Ven Annenienke , Yavropoulou Maria , Selby Peter

PRIMARA is the first observational study to describe the demographic and clinical profiles of adults with primary hyperparathyroidism (pHPT) receiving cinacalcet in daily clinics across European countries.Patients with pHPT aged ≥18 years without prior cinacalcet treatment were eligible. Initial cinacalcet dosage and subsequent dose changes were at the investigator’s discretion. Information on dosing, biochemistry and adverse drug reactions (A...

ea0081yi11 | Young Investigator Awards | ECE2022

Diagnosing pancreatic neuroendocrine tumors in patients with multiple endocrine neoplasia type 1 in daily practice

Pieterman Carolina , Van Beek Dirk-Jan , Wessels Frank J , van de Ven Annenienke C , de Herder Wouter W , Dekkers Olaf M , Zandee Wouter T , Drent Madeline L , Bisschop Peter H , Havekes Bas , Borel Rinkes Inne HM , Vriens Menno R , Valk Gerlof D

Background: Pancreatic Neuroendocrine Tumors (PanNETs) are highly prevalent in Multiple Endocrine Neoplasia type 1 (MEN1) and one of the main causes of mortality. Conventional imaging is the mainstay of PanNET screening/surveillance in MEN1. This study aims to assess the diagnostic accuracy of conventional pancreatic imaging studies and to determine the added value of pancreatic fine needle aspirations (FNA) for the diagnosis of MEN1-related PanNETs.Meth...